Elemental Iodine Or Iodine Compound Patents (Class 424/667)
-
Publication number: 20100143473Abstract: A combination treatment, wherein a strontium-containing compound together with one or more active substances capable of reducing the incidence of bone fracture and/or increasing bone density and/or improving healing of fractured bone and/or improving bone quality are administered for use in the treatment and/or prophylaxis of cartilage and/or bone conditions.Type: ApplicationFiled: May 4, 2009Publication date: June 10, 2010Inventors: Christian Hansen, Henrik Nilsson, Stephan Christgau
-
Patent number: 7704531Abstract: An antiperspirant composition comprising an antiperspirant salt selected from an aluminum antiperspirant salt, an aluminum-zirconium antiperspirant salt, and a mixture thereof; a betaine component selected from betaine, betaine hydrochloride, and a mixture thereof; a calcium salt; and water.Type: GrantFiled: February 6, 2006Date of Patent: April 27, 2010Assignee: Colgate-Palmolive CompanyInventors: Sheridan Tang, Marian N. Holerca, Donghui Wu, Christine M. Popoff
-
Patent number: 7699906Abstract: The present invention relates to iodinated resins. It relates in particular to a process for preparing a polyiodide-resin wherein an anion exchange resin is contacted with a material capable of donating a member absorbable by the resin so as to convert the resin to the polyiodide-resin. The absorbable member is selected from the group consisting of I.sub.2 and polyiodide ion having a valence of ?1. In the process, conversion of the anion exchange resin to the polyiodide-resin is effected at elevated temperate and/or elevated pressure, the elevated temperature being about 100.degree. C. or higher, the elevated pressure being greater than atmospheric pressure. The present invention also relates to a substance comprising an iodine (impregnated) resin as produced by the above process.Type: GrantFiled: July 25, 2007Date of Patent: April 20, 2010Assignee: Triosyn Holding Inc.Inventor: Pierre Jean Messier
-
Publication number: 20100068304Abstract: The invention relates to compositions for preventing and/or treating cardiovascular diseases in felines with hyperthyroidism wherein the compositions comprise from about 0.07 to less than about 1 mg/kg iodine and/or from about 0.1 to about 1.3 mg/kg selenium. The invention also relates to methods for preparing and using such compositions. articles of manufacture comprising such compositions, and means for communicating information about such compositions. methods, and articles of manufacture.Type: ApplicationFiled: July 3, 2007Publication date: March 18, 2010Applicant: HILL'S PET NUTRITION, INC.Inventors: Karen Joy Wedekind, Claudia Ann Kirk
-
Publication number: 20100021566Abstract: A formulation or preparation for treating and preventing arterial and venous thrombi is provided. This preparation includes a non-metal containing photodynamic dye and a fat soluble vitamin. A method of administration for treatment and prophylaxis of arterial and venous thrombi is also provided. This method includes steps of: combining a non-metal containing photodynamic dye and a fat soluble vitamin; combining the non-metal containing photodynamic dye and fat soluble vitamin with a sodium solution; and administering the combination of non-metal containing photodynamic dye, fat soluble vitamin, and sodium solution as an intravenous drip.Type: ApplicationFiled: July 28, 2008Publication date: January 28, 2010Inventor: David E. Winslow
-
Publication number: 20090324518Abstract: The invention refers to novel compositions with at least one prehormone, hormone from group consisting of mevalonate derivatives or from the group consisting of peptides and/or proteo-hormones and at least one mineral, one constituent by preference from the group consisting of iodine, selen and at least one Ginkgoloide against alkyl-acyl-GPC (AAGPC), its derivatives (alkyl-lipis) and/or products (e.g. acetylacyl-CoA). In addition, the invention also refers to the manufacture of novel compositions with at least one Ginkgoloide and/or acetylcysteine for oral, dietary, oily or local, cosmetic administration. Novel local preparations without ether/volatile oils contain Ginkgoloides with at least one sun screening agent against impairments of pigmentation. The compositions of the invention are used for the manufacture of compounds to protect against alkylacyl-like destabilized cells by preference under the conditions of critical lifestyle.Type: ApplicationFiled: December 21, 2006Publication date: December 31, 2009Applicant: Consigllo Nazionale Delle RicercheInventor: Ruth-Maria Korth
-
Publication number: 20090324737Abstract: Germicidal compositions with enhanced activity towards killing microbiological spores and vegetative cells comprising certain quaternary ammonium compounds (QACs), phenolic compounds, monohydric alcohols, hydrogen peroxide, iodine, triclocarban, triclosan or combinations thereof with one or more spore coat opening agents. The invention also provides for the application of the germicidal compositions to animate and inanimate surfaces to help kill germs and protect against the risk of infection from bacteria, molds, yeasts, fungi, viruses, and microbiological spores.Type: ApplicationFiled: August 13, 2009Publication date: December 31, 2009Inventor: Edward B. Walker
-
Publication number: 20090311175Abstract: The invention provides methods for enhancing iodine absorption in a thyroid in a subject and treating thyroid cancer by administering to the subject a composition which includes a multi-kinase inhibitor. Furthermore, the invention provides methods for improving a medical diagnostic procedure based on radioactive iodine in a subject by administering to the subject a composition comprising a multi-kinase inhibitor.Type: ApplicationFiled: May 7, 2009Publication date: December 17, 2009Inventor: Marcia S. Brose
-
Publication number: 20090312706Abstract: Described herein are transdermal delivery devices composed of at least one resealable injection port and at least one local anesthetic reservoir. The device effectively delivers anesthetic to the skin of the subject prior to puncturing the skin by syringes, needle sticks, or other instruments intended to be inserted into the skin. In addition, this device can be used to deliver various therapeutic agents for either locally or systemically.Type: ApplicationFiled: April 16, 2009Publication date: December 17, 2009Inventors: Totada Shantha, Jessica Shantha, Erica Shantha, Lauren Shantha
-
Publication number: 20090280193Abstract: Alternative cellular energy pigments (ACE-pigments) provide a source of cellular energy other than that provided through the oxidative metabolism of foods, or in the case of plants and certain bacteria, through the process of photosynthesis. In some patients, ACE pigments exist in a form that can be further energized or activated using ultraviolet (UV) light, especially if the reaction is initially triggered by the presence of suitable dyes, such as neutral red. A method is described to further enhance the activation of the ACE pathway in humans and animals deprived of ACE. The method comprises using natural or man-made sources of ACE products (enerceuticals), with or without the inclusion of a suitable dye, such as neutral red; or other activating components, such as magnesium chloride; with the combined mixture being put into a UV transparent container, such as a plastic bag, or placed on some other material, which can be laid onto the skin and illuminated with a UV light source.Type: ApplicationFiled: May 8, 2008Publication date: November 12, 2009Applicant: MI Hope Inc.Inventor: William John Martin
-
Publication number: 20090269416Abstract: The invention relates to compositions for preventing chronic renal failure (CRF) in felines with hyperthyroidism wherein the compositions comprise (1) from about 28 to about 35% protein, the protein comprising at least about 75% vegetable protein, and (2) from about 0.1 to less than about 1 mg/kg iodine and/or from about 0.1 to about 1 mg/kg selenium. The invention also relates to compositions for treating CRF in hyperthyroid felines wherein the compositions comprise (1) from about 28 to about 35% protein, the protein comprising at least about 75% vegetable protein, and (2) from about 0.1 to less than about 0.3 mg/kg iodine and/or from about 0.1 to about 1 mg/kg selenium. The invention further relates to methods for preparing and using such compositions, articles of manufacture comprising such compositions, and means for communicating information about such compositions, methods, and articles of manufacture.Type: ApplicationFiled: May 14, 2007Publication date: October 29, 2009Applicant: HILL'S PET NUTRITION , INC.Inventors: Karen Joy Wedekind, Timothy Arthur Allen, Dale Allen Fritsch, Chadwick Everett Dodd
-
Publication number: 20090246146Abstract: The present invention relates to the use of halides and halide salts for the treatment of microbial infections, including those caused by bacteria, fungi and viruses. The present invention takes advantage of endogenous immune function and augments this system using a non-toxic and inexpensive reagent that can be delivered to mucosal surfaces, for example, orally, topically, opthalmically and via inhalation.Type: ApplicationFiled: January 9, 2009Publication date: October 1, 2009Inventors: BOTOND BANFI, Anthony Fischer, Joseph Zabner, Lakshmi Durairaj, Daniel Lorentzen, Paul B. McCray, JR.
-
Publication number: 20090226541Abstract: Methods of delaying the onset of an infection or preventing an infection caused by a microbial organism in an internal cavity of a subject are provided. Methods of killing or inactivating microorganisms in at least a portion of the urethra of a subject are provided.Type: ApplicationFiled: March 10, 2006Publication date: September 10, 2009Applicant: 3M INNOVATIVE PROPERTIES COMPANYInventors: Matthew T. Scholz, Terry R. Hobbs, Danli Wang
-
Publication number: 20090226540Abstract: Methods for treating feline hyperthyroidism comprising (1) administering to a feline an antithyroid agent in conjunction with feeding the feline a composition comprising from about 0.1 to less than about 1 mg/kg iodine or (2) feeding the feline a composition comprising from about 0.1 to less than about 1 mg/kg selenium on a dry matter basis.Type: ApplicationFiled: January 26, 2007Publication date: September 10, 2009Applicant: HILL's PET NUTRITION INCInventors: Karen Joy Wedekind, Dale Allen Fritsch, Chadwick Everett Dodd, Timothy Arthur Allen
-
Publication number: 20090169647Abstract: The present invention relates to compositions that contain iodine intended primarily for tissue antisepsis, particularly skin antisepsis.Type: ApplicationFiled: December 29, 2008Publication date: July 2, 2009Inventor: Matthew T. Scholz
-
Publication number: 20090162301Abstract: The present invention provides antiseptic compositions that contain DMSO or DMA, an alcohol (e.g., isopropanol), and/or an additional antiseptic agent such as iodine. In certain embodiments, the antiseptic compositions may be used for skin disinfection and/or skin antisepsis (e.g., as applied via a swab).Type: ApplicationFiled: June 9, 2006Publication date: June 25, 2009Inventor: Jeffrey J. Tarrand
-
Publication number: 20090142314Abstract: The use of docosahexaenoic acid in the manufacture of a composition for administration to a pregnant woman for reducing the risk of development of overweight or obesity of the baby in infancy and/or early childhood.Type: ApplicationFiled: May 22, 2007Publication date: June 4, 2009Applicant: NESTEC S.A.Inventors: Ferdinand Haschke, Zdenek Kratky
-
Publication number: 20090142415Abstract: Chemical compositions may be selectively or preferentially excited by the application of scores comprising a series of energy inputs.Type: ApplicationFiled: November 19, 2008Publication date: June 4, 2009Applicant: Searete LLCInventors: Muriel Y. Ishikawa, Edward K.Y. Jung, Nathan P. Myhrvold, Lowell L. Wood, JR.
-
Publication number: 20090130223Abstract: The development relates to cosmetic and dermatological preparations containing aquaporin stimulators, in particular glyceryl glycosides, and their use to improve the moisturizing of the skin.Type: ApplicationFiled: March 28, 2007Publication date: May 21, 2009Inventors: Ute Breitenbach, Wilfried Siefken, Tanja Delekat, Lara Terstegen, Helga Biergiesser, Franz Staeb, Gunja Springmann
-
Publication number: 20090123569Abstract: A composition having various color changing tannates may be used to indicate that the composition has dried. The tannates change color in contact with an acid. The composition may be, for example, a skin prep, skin sealant, food product, paint or other building material or other product that undergoes a phase change. The tannate may be added either directly to the composition, incorporated into a sponge on an applicator through which the composition is dispensed and applied, applied separately or applied simultaneously from a separate reservoir. The amount of tannate in the composition can be adjusted to provide a visual cue to the user of the application area and the extent of cure.Type: ApplicationFiled: November 8, 2007Publication date: May 14, 2009Inventors: John Gavin MacDonald, Molly K. Smith, Iiona F. Weart, Phillip A. Schorr
-
Publication number: 20090098081Abstract: A system for providing a method of sealing skin with a film forming polymer is provided. The system includes providing an at least two part applicator containing a sealant composition in one or more frangible containers, providing instructions for using the applicator associated therewith, where the method including moving at least one of said applicator parts from a first position to a second position and applying said sealant to skin. The composition has film former, a plasticizer and 3000 to 10000 ppm of a dye that changes color when is undergoes a phase change. The color change is visible to a human eye under normal light conditions. changing dyes may be used to indicate that the composition has dried. The dyes change color in response to the phase change, i.e., drying of the film former.Type: ApplicationFiled: October 12, 2007Publication date: April 16, 2009Inventors: John Gavin MacDonald, Molly K. Smith, Ilona F. Weart, Phillip A. Schorr
-
Publication number: 20090068190Abstract: Combinations of a polyunsaturated fatty acid and diindolylmethane and pharmaceutical composition containing such combinations. Further provided are combinations including a polyunsaturated fatty acid, diindolylmethane, and folic acid. Also provided are combinations including diindolylmethane and folic acid. Also provided is a method for increasing the number of normal cells and decreasing the number of aberrant cells in a subject having the steps of administering to the subject a combination comprising a polyunsaturated fatty acid and diindolylmethane.Type: ApplicationFiled: August 27, 2008Publication date: March 12, 2009Applicant: DRUGTECH CORPORATIONInventor: Jonathan David Bortz
-
Publication number: 20090041859Abstract: [Problems] The objective is to provide a new low-toxic drug for external use for intractable diseases, such as erosion, decubitus, and skin ulcer, that prevents cicatrization and reduces iodine accumulation on wound surfaces with sufficiently promoting healing. [Means for solving problem] Preparation of a wound treatment drug for external use containing oily bases and iodine but substantially no white soft sugar, which is a characteristic of the drug of this invention. The invented drug prevents infection through the wound surface due to a sufficient bactericidal effect of iodine, and promotes wound healing, prevents cicatrization and reduces iodine accumulation on the wound surface by maintenance of appropriate moisture in the wound surface due to a moisturizing effect of oily bases.Type: ApplicationFiled: April 7, 2006Publication date: February 12, 2009Applicants: Mie University, MARUISHI PHARMACEUTICAL CO., LTD.Inventors: Hitoshi Mizutani, Yoshiaki Miyamoto, Atsushi Nishikawa
-
Publication number: 20090028915Abstract: An article is applied to the surface of an article, animal housing environment or animal (including humans) to provide antimicrobial activity when activated with a liquid comprising alcohol. The article may comprise a water and/or alcohol absorbent material; and a composition that reacts with water and/or alcohol to produce molecular iodine. The composition provides a local concentration (in the water and/or alcohol) of at least 5 or 10 parts per million iodine in water and/or alcohol carried by the material (that is actual water supported by the water absorbent material) when the material has 5% by weight of water present in the water absorbent.Type: ApplicationFiled: July 24, 2008Publication date: January 29, 2009Inventor: Kenneth R. Code
-
Publication number: 20090022780Abstract: The invention is related to gel preparations capable of absorbing as well as releasing liquid, and the use of such gel preparations in the treatment of wounds.Type: ApplicationFiled: January 31, 2007Publication date: January 22, 2009Applicant: EURO-CELTIQUE S.A.Inventors: Sabine Scherer, Christian Wagner, Christian Leuner, Wolfgang Fleischer
-
Publication number: 20090022816Abstract: This discovery is storable, pre-nascent iodine that activates and: produces nascent iodine over a two-to-three-hour period within the body when diluted in water and consumed. The iodine is in a low concentration in a tincture of grain alcohol. A quantity of tincture is submerged in a glass container in an electrolytic bath between two electrodes and subjected to a specific amperage for a period of time. This action causes the diatomic bond of the iodine molecule to be broken with the iodine atom receiving excitation energy from the magnetic field. When diluted and consumed into the body, the nascent iodine is able to produce significant beneficial effects in the body.Type: ApplicationFiled: September 5, 2006Publication date: January 22, 2009Inventor: John Staley Brookshire
-
Publication number: 20090017139Abstract: A method for therapeutically treating medical conditions requiring chronic therapy such as fibrocystic breast disease, endometriosis, ovarian cysts, uterine fibroids and including the treatment of women considered to be at risk to breast and/or ovarian cancer without causing an overt thyroid disease by first administering to a patient a daily loading dose of molecular iodine (I2) for a time period not to exceed six months and preferably 2 to 4 months at a concentration level sufficient to remediate symptoms associated with the medical condition followed by daily dosing with a maintenance dose of I2 after treatment of the loading dose is completed with the concentration of the maintenance dose being substantially less than the concentration of the loading dose.Type: ApplicationFiled: July 12, 2007Publication date: January 15, 2009Inventor: Jack Kessler
-
Publication number: 20090004296Abstract: A novel antiseptic composition comprising an antiseptic in a carrier composition comprising nanostructures and a liquid and methods of use thereof are provided.Type: ApplicationFiled: January 4, 2007Publication date: January 1, 2009Inventor: Eran Gabbai
-
Publication number: 20080260716Abstract: Methods and compositions for high level disinfection (as herein defined) of a surface. Methods include treating the surface with a composition including a quaternary ammonium compound in a concentration which exceeds 1% w/w and the temperature of treatment is in the range of from 30° C. to 80° C. A log (6) reduction in Mycobacterium terrae is achieved on the surface in less than 10 minutes. The temperature may be produced by a physical chaotrope, a chemical chaotrope (such as) boron or a boron compound or complex or a combination of chaotropic agents. Sequestering agents and enzymes maybe added.Type: ApplicationFiled: July 5, 2005Publication date: October 23, 2008Applicant: Nanosonics Pty LimitedInventors: Steven Kritzler, Alex Sava
-
Publication number: 20080260788Abstract: The present invention describes a skin cleaning and disinfecting composition comprising an active component, wherein the active component comprises at least one alcohol, at least one halogen. The present invention also describes corresponding anti-bacterial, anti-viral and anti-fungal compositions, as well as a method of manufacturing same.Type: ApplicationFiled: May 17, 2005Publication date: October 23, 2008Applicant: GREENBRIDGE ENVIRONMENTAL CONTROL LIMITEDInventors: Christopher Malyszewiez, Ian Geoffrey Pears, Rae Clyde Levene
-
Publication number: 20080248135Abstract: Otitis is treated with a combination of a controlled-release iodine preparation and a pH-lowering preparation. This prevents or delays the onset of antibiotic resistance among causative bacteria and fungi, and, by inhibiting protease activity, improves the rate of healing, and prevents Pseudomonas bacteria from spreading into the temporal bone.Type: ApplicationFiled: July 27, 2007Publication date: October 9, 2008Inventors: Mark Hirsh, Mark Vecchiotti
-
Publication number: 20080247979Abstract: The invention describes the use of a hydrophobic zeolite, that contains an active component, especially a disinfection element, as ethanol, iodine, phenol, cresol or hydrogen peroxide, in a composition for non-medical treatment of the skin, for example as a deodorant. The invention also describes the use of a hydrophobic zeolite, that contains an active component, especially a disinfection element, as ethanol, iodine, phenol, cresol or hydrogen peroxide, for manufacturing of a pharmaceutical preparation for treatment of skin related conditions and diseases, as skin infections. The hydrophobic zeolite is especially selected from that group that comprises silicalite, or hydrophobic ZMS-5, hydrophobic mordenite and hydrophobic zeolite Y.Type: ApplicationFiled: March 13, 2006Publication date: October 9, 2008Inventors: Hakan Benjaminson, Stan Anderson
-
Publication number: 20080226744Abstract: A composition including a unique combination of fruits, vegetables, herbs, and optionally vitamins, minerals and specialty ingredients. The composition can include a fruit ingredient, a vegetable ingredient and an herbal ingredient, wherein the fruit ingredient is at least one of pomegranate and citrus bioflavonoids, wherein the vegetable ingredient, is at least one of asparagus, lutein, lycopene and watercress, and wherein the herbal ingredient is at least one of basil, oregano and rosemary. The composition can be administered to subjects to correct a dietary deficiency of phytochemicals and other nutrients, improve plasma concentrations of antioxidant nutrients, and increase the activity of genetic mechanisms for DNA repair and stability.Type: ApplicationFiled: March 31, 2008Publication date: September 18, 2008Applicant: ACCESS BUSINESS GROUP INTERNATIONAL LLCInventors: Ruo G. HUANG, Stephen R. MISSLER, Marc J.P. LEMAY, Edward S. KAHLER, Donald J. PUSATERI, Haeri ROH-SCHMIDT, Shyam RAMAKRISHNAN
-
Publication number: 20080193562Abstract: A process reduces the insect, arthropod or pest content in land mass by providing molecular iodine in the land mass in a concentration in aqueous material in the land mass of at least 10 parts per million. The molecular iodine may be added in gaseous or liquid or solid state, and may be formed in situ in the land mass using available water in the reaction.Type: ApplicationFiled: January 31, 2008Publication date: August 14, 2008Inventor: Kenneth R. Code
-
Publication number: 20080152724Abstract: Compositions for the treatment of periodontitis and methods of use thereof are described. The compositions contain a polymer-iodine complex. The polymer-iodine complex can be suspended in a pharmaceutically acceptable carrier in which the complex is stable and the iodine is stable in its elemental form and/or a combined form (e.g., iodine-iodide complex). In one embodiment, the complex is prepared by the reacting a synthetic or semi-synthetic ionic polymer, with iodine and/or an iodide. The complex will preferably deliver iodine over an extended period of time for example over several days (e.g., at least 3 days, preferably at least 4 days, more preferably at least 5 days, most preferably at least 6 days), preferably at least a week, more preferably at least two weeks. In one embodiment, the polymer-iodine complex forms a gel, alone or by the addition of one or more gelling agents, upon administration into a periodontal pocket.Type: ApplicationFiled: December 21, 2007Publication date: June 26, 2008Inventor: Mark Hirsh
-
Publication number: 20080113037Abstract: Embodiments relate generally to topical compositions useful for treating or preventing a variety of cosmetic conditions and dermatological disorders, where the composition comprises an oxidative pharmaceutical drug and an antioxidant polyhydroxy acid or polyhydroxy lactone. The polyhydroxy acid or polyhydroxy lactone improves the cutaneous effects of the drug. The embodiments further relate to the treatment of a variety of cosmetic conditions and dermatological disorders comprising administering to a subject an effective amount of the composition and to methods of making the compositions.Type: ApplicationFiled: March 5, 2007Publication date: May 15, 2008Inventors: Barbara A. Green, David J. Milora
-
Publication number: 20080019955Abstract: The invention relates to a biodegradable barrier network comprising at least two polypeptides, one being anionic and the other one cationic. The invention also relates to applicators and kits comprising components to be used to create said biodegradable barrier network. The invention also relates to the use of said applicator or kit in therapy, such as in medicine, veterinary medicine and horticulture.Type: ApplicationFiled: December 23, 2004Publication date: January 24, 2008Applicant: Bioactive Polymers ABInventors: Stig Bengmark, Kare Larsson, Bjorn Lindman, Roland Andersson
-
Publication number: 20070298126Abstract: A method for killing or substantially eradicating a pathogen in the upper respiratory tract of a mammal is disclosed. The method comprises generating molecular iodine (I2) in situ using an oxidant-reductant reaction with a minimum concentration of at least about 25 ppm of I2 and I2 comprises at least 40% of the total iodine atoms. A method for inhibiting superantigens using molecular iodine is also disclosed.Type: ApplicationFiled: June 22, 2006Publication date: December 27, 2007Inventors: Jack Howard Kessler, James Carlton Richards
-
Patent number: 7285292Abstract: The invention discloses a trace element solution, which comprises at least one metal selected from the group comprising selenium, copper, zinc, manganese and chromium and which comprises a concentration of the metal(s) of at least 60 mg/ml. The solution further comprises at least one compound selected from the group comprising iodine, potassium iodide, sodium iodide, iron, iron chloride, zinc oxide, manganese sulphate, sodium selenite, copper carbonate, sodium carbonate, anhydrous disodium EDTA and sodium hydroxide. The trace element solution is prepared by a method consisting essentially of the steps of preparing a MnCO3 mixture in a container; adding an EDTA/NaOH mixture to the container and subsequently adding at least one metal compound; and adding Na2SeO3 to the container to obtain the trace element solution. The method also comprises the step of adding CrCl3.6H2O to the trace element solution.Type: GrantFiled: April 29, 2004Date of Patent: October 23, 2007Assignee: Warburton Technology LimitedInventors: Robert Naylor Laurie, William Alfred Smith
-
Patent number: 7192601Abstract: Germicidal compositions with enhanced activity towards killing microbiological spores and vetgetative cells comprising certain quaternary ammonium compounds (QACs), phenolic compounds, monohydric alcohols, hydrogen peroxide, iodine, triclocarban, triclosan or combinations thereof with one or more spore coat opening agents. The invention also provides for the application of the germicidal compositions to animate and inanimate surfaces to help kill germs and protect against the risk of infection from bacteria, molds, yeasts, fungi, viruses, and microbiological spores.Type: GrantFiled: January 16, 2003Date of Patent: March 20, 2007Inventor: Edward B. Walker
-
Patent number: 7182937Abstract: A composition for reducing dentinal hypersensitivity and remineralizing exposed dentinal surface and open dentinal tubules, comprising a non-aqueous carrier and a desensitizing amount of a desensitizing/remineralizing agent which consists essentially of a water soluble calcium salt and an incompatible ingredient which would otherwise react with the calcium salt. Upon contact with saliva when applied to an oral cavity, the desensitizing/remineralizing is then formed in situ by the reaction between the calcium salt and the incompatible ingredient, thereby remineralizing exposed dentinal surface and open dentinal tubules.Type: GrantFiled: October 10, 2001Date of Patent: February 27, 2007Assignee: Block Drug Company, Inc.Inventors: Jin Xu, Stephen W. Mruphy, Bala Nayar, Michael E. Trama
-
Patent number: 7179327Abstract: Treatment and preservation of wood, wood fiber products, and porous surfaces with a stabilized solution of periodic acid or iodic acid is provided.Type: GrantFiled: November 20, 2002Date of Patent: February 20, 2007Inventor: Glenn P. Wampole, Sr.
-
Patent number: 7153527Abstract: A teat dip composition comprising from about 0.1% to about 2% iodine by weight of the composition on a formulation basis and form about 45% to about 99.9% propylene glycol by weight of the composition on a formulation basis, and a method of using such composition to treat mastitis.Type: GrantFiled: June 7, 2005Date of Patent: December 26, 2006Assignee: WestfaliaSurge, Inc.Inventors: Charles D. Gradle, Alejandro O. Dee
-
Patent number: 7078059Abstract: The invention provides a method for enhancing bone formation, inhibiting osteoclastic differentiation and/or activating osteoblastic differentiation whereby to manage, treat or achieve prophylaxis of bone disease which comprises administering to a human or animal subject suffering from, or susceptible to bone disease a therapeutically or prophylactically effective amount of a lanthanum compound.Type: GrantFiled: June 26, 2001Date of Patent: July 18, 2006Assignee: Shire Holdings AGInventors: Nigel D. Atherton, Joseph William Totten, Michael David Gaitonde
-
Patent number: 7014871Abstract: An iodine preparation composition suitable for use on wounds comprising an iodide source, an oxidant and a buffer characterized in that the iodide is held separately from the oxidant until the point of use, and that the buffer is capable of maintaining the pH of the composition at between pH 45 and pH 6 so that iodine is generated at a physiologically acceptable dose rate.Type: GrantFiled: March 13, 2000Date of Patent: March 21, 2006Inventors: Dave Parsons, Elizabeth Jacques, Philip Bowler
-
Patent number: 6962714Abstract: The present invention relates to antimicrobial compositions including a critical, near critical, or supercritical (densified) fluid and an antimicrobial agent, to methods of forming these compositions, and to methods employing these compositions. An antimicrobial agent can be generated in the presence of a densified fluid, for example, by reacting an oxidizing agent with a precursor to the antimicrobial agent.Type: GrantFiled: August 6, 2002Date of Patent: November 8, 2005Assignee: Ecolab, Inc.Inventors: Robert D. P. Hei, Keith E. Olson, Robert J. Ryther, Richard K. Staub
-
Patent number: 6939569Abstract: There is disclosed a medical device for implantation that acts to prevent transmission of infectious agents. Specifically, the present invention provides implantable devices, such as catheters or living skin matrices or wound dressings, for insertion into various body cavities or over wound sites to confer to the site microbicidal or virucidal activity. Devices in the disclosure designed as vaginal inserts also exhibit contraceptive spermicidal activity. The coated devices or devices having the inventive polymeric material interspersed throughout are formed into appropriate shapes according to their contemplated uses (such as catheters or Foley catheters). Further, the present invention provides devices for providing therapeutic anti-microbial activity into an infected body cavity or on an infected wound site.Type: GrantFiled: June 18, 1999Date of Patent: September 6, 2005Assignee: Oxibio, Inc.Inventors: Terrence R. Green, Jack Fellman
-
Patent number: 6932966Abstract: A skin treatment mixture for treating pierced skin such as that resulting from a body piercing procedure includes sea salt, lysozyme and reconstituted ocean water. The reconstituted ocean water preferably is the product of reverse osmosis of water. The skin treatment mixture preferably additionally includes sodium benzoate to act as a preservative. A method of producing a skin treatment mixture includes the steps of providing a quantity of purified water; adding a quantity of sea salt to the quantity of purified water; boiling the purified water and sea salt; cooling the purified water and sea salt; adding a quantity of lysozyme to the purified water and sea salt; sterilizing the mixture and testing it for bacteria. A method of treating a pierced skin area includes the step of applying to the pierced area a reconstituted ocean water mixture of sea salt and lysozyme.Type: GrantFiled: June 20, 2003Date of Patent: August 23, 2005Inventor: Edward Kolos
-
Patent number: 6926913Abstract: The invention provides a composition of matter comprising molecular iodine and tetraglycol.Type: GrantFiled: March 22, 2001Date of Patent: August 9, 2005Assignees: Ben Gurion University of the Negev Research & Development Authority, Yissum Research Development Company of the HebrewInventors: Uri Wormser, Amnon Sintov
-
Patent number: 6908628Abstract: Wide spectrum disinfecting and antiseptic composition for use in the fields of human medicine, veterinary science and industry, characterized because it includes: Hydrogen peroxide, lactic acid and halogen salts (Br, I) and/or salts of heavy metals (for example, silver halides) with surfactant agents, either cationic, like chlorhexidine and/or quaternary ammonium salts, like didecyl-methyl-polyoxy-ethyl-ammonium propionate, chlorides of ammonium or compounds of ammonium propylamide or anionic, like lauryl sulphate, dodecyl sulphate or alkyl succinic salts, with suitable excipients, some of which may be ethyl or isopropyl alcohol, chlorhexidine, non-chlorinated quaternary ammonium salts, like didecyl-methyl-polyoxy-ethyl-ammonium propionate, combined or not with iodine, and/or its salts, together with excipients, some of which may be ethyl or isopropyl alcohol.Type: GrantFiled: June 10, 2002Date of Patent: June 21, 2005Assignee: OFTRAI, S.L.Inventor: Rafael Herruzo Cabrera